

In the meta analysis described in the two graphics above, the studies showed positive results with Ivermectin, reported here in detail: https://c19ivm.org/
In the short video by Epoch Times at the following link, the conflict by the U.S. FDA’s position is described: https://www.ganjingworld.com/s/27wEGxwbJ
FDA website:
About halfway down the FDA page at the link above: “Currently available data do not show ivermectin is effective against COVID-19. Clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing.”
Contrary to the FDA’s statement above, on this FDA list below of ivermectin clinical trials, most of the 36 completed studies found ivermectin was effective against corona virus.
For example, in this randomized, controlled study below looking through and comparing the tabular results, the patients in the trial did better (for example, high lymphocyte counts, higher oxygenation) with fewer side effects and adverse events than the control patients who received no ivermectin. This report does not include its own conclusions.
Ivermectin for Severe COVID-19 Management
ClinicalTrials.gov ID NCT04646109
Another type of study:
Published in June, 2020 in the journal Anti-viral Research, the laboratory (i.e., non-clinical, invitro) study at the link showed a 5000 fold reduction in viral mRNA only 48 hours after a single dose of ivermectin.
“We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.” https://pubmed.ncbi.nlm.nih.gov/32251768/
The 2020 research report at the following link explains the mechanism of action of ivermectin (how and why it works): https://www.researchgate.net/publication/344315325_Ivermectin_as_a_Broad-Spectrum_Host-Directed_Antiviral_The_Real_Deal
In Australia…ivermectin prescriptions are no longer limited.
“From 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.”
In its final decision published today, the Therapeutic Goods Administration (TGA) has removed the restriction through its scheduling in the Poisons Standard because there is sufficient evidence that the safety risks to individuals and public health is low when prescribed by a general practitioner in the current health climate.”
https://www.tga.gov.au/news/media-releases/removal-prescribing-restrictions-ivermectin
You must be logged in to post a comment.